Evidence map›Paper›PMID 40405932›Full record

ReviewJournal of medicine and life2025

Risk factors and predisposing conditions for amniotic fluid embolism: a comprehensive review.

Jumana Hussain Timraz, Ruqayyah Ali Ahmed, Nada Yasser Metwali, Zenab Javed, Shahd Abdelazim, Raabeah Farhan, Faten Ahmad Yaseen, Hossam Abdelfatah Mansour

Abstract readReview
In one paragraph

Review in Journal of medicine and life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jumana Hussain TimrazDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Ruqayyah Ali AhmedDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Nada Yasser MetwaliDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Zenab JavedDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Shahd AbdelazimDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Raabeah FarhanDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Faten Ahmad YaseenDepartment of Medicine and Surgery, Batterjee Medical College for Science and Technology, Jeddah, Saudi Arabia.
Hossam Abdelfatah MansourDepartment of Obstetrics and Gynecology, Aya Specialist Hospital, Jeddah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amniotic fluid embolism (AFE) is a rare, yet life-threatening obstetric emergency characterised by sudden collapse of the mother due to circulatory and respiratory failure, often accompanied by coagulopathy. It accounts for a significant proportion of peripartum cardiac arrests and maternal deaths, with an incidence of 2-8 per 100,000 deliveries. The specific pathophysiology behind AFE remains unclear. However, one hypothesis states that amniotic fluid or fetal debris enters the maternal circulation, triggering a severe inflammatory and immunologic response. Diagnosis of AFE is primarily clinical as it relies on exclusion due to the unavailability of any definitive diagnostic test. Risk factors include caesarean delivery, multiple pregnancies, advanced maternal age, and pre-existing health conditions or comorbidities. Effective management centres on early recognition, aggressive, urgent supportive measures, and resuscitation. Advanced therapeutic options, such as veno-arterial extracorporeal membrane oxygenation (VA-ECMO), have shown potential in severe cases. Despite medical advancements in supportive care, which have led to reduced mortality rates, AFE remains highly unpredictable, carrying a significant risk of maternal and fetal mortality and morbidity. Survivors are often faced with long-term complications such as neurological deficits and cardiac problems. This comprehensive review aims to improve clinicians' awareness of AFE, summarize its risk factors, and provide an overview of the current strategies for early recognition and management, emphasizing recent advancements and the need for continued research in this critical area.

Indexed as

Embolism, Amniotic FluidExtracorporeal Membrane OxygenationFemaleHumansPregnancyRisk Factorsamniotic fluid embolismcoagulopathyfetal debrispostpartum

Identifiers

PMID40405932
PMCPMC12094319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.